Home
About
FAQ
History (67)
Organic Cation Transporter 1
Weight Management without Stigma or Harm: A Roundtable Discussion with Childhood Obesity Experts.
Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis.
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants.
Patients as stakeholders in setting kidney disease research priorities.
See All 67 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Patients as stakeholders in setting kidney disease research priorities.
Navaneethan SD, Boulware LE, Sedor JR. Patients as stakeholders in setting kidney disease research priorities. Am J Kidney Dis. 2015 May; 65(5):641-3.
View in:
PubMed
subject areas
Biomedical Research
Decision Making
Humans
Kidney Diseases
Nephrology
authors with profiles
Leigh E. Boulware MD, MPH